Theravance and GSK in Alliance to Develop Respiratory Drugs
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 32 (Table of Contents)
Published: 3 Jan-2003
DOI: 10.3833/pdr.v2003.i32.952 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GlaxoSmithKline (GSK) formed an alliance with Theravance to develop long acting beta2 agonist (LABA) drugs for treating respiratory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS